drugset / Trial / NCT01596894

Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease

NCT01596894

Phase 4 Completed 73 enrolled Prof. Arie Levine
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate effectiveness of 2 months antibiotic course of Azithromycin combined with Metronidazole compared with 2 months antibiotic course of Metronidazole alone.

Timeline

Start
2012-10
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 7.5 mg/kg Oral
Subject Metronidazole Small molecule 10 mg/kg Oral

Indications